11/12/2010

Johnson & Johnson unit Centocor Ortho Biotech has applied for FDA approval of injectable drug Simponi for delaying progression of joint damage in patients with active psoriatic arthritis. Simponi already is approved to treat the condition as well as rheumatoid arthritis.

Related Summaries